DAWN

Day One Biopharmaceuticals, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$21.45

Market Cap

$2.22B

Beta

-1.25

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+20.60%

EPS Growth (YoY)+4.64%

Revenue CAGR 3Y+0.00%

P/E Ratio0.0

PEG Ratio—

FCF Yield-4.86%

Debt / Equity0.01

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for DAWN.